NR2E3 is a key component in p53 activation by regulating a long noncoding RNA DINO in acute liver injuries.


Journal

FASEB journal : official publication of the Federation of American Societies for Experimental Biology
ISSN: 1530-6860
Titre abrégé: FASEB J
Pays: United States
ID NLM: 8804484

Informations de publication

Date de publication:
07 2019
Historique:
pubmed: 17 4 2019
medline: 20 5 2020
entrez: 17 4 2019
Statut: ppublish

Résumé

Damage-induced long noncoding RNA (DINO) is a long noncoding RNA that directly interacts with p53 and thereby enhances p53 stability and activity in response to various cellular stresses. Here, we demonstrate that nuclear receptor subfamily 2 group E member 3 (NR2E3) plays a crucial role in maintaining active DINO epigenetic status for its proper induction and subsequent p53 activation. In acetaminophen (APAP)- or carbon tetrachloride-induced acute liver injuries, NR2E3 knockout (KO) mice exhibited far more severe liver injuries due to impaired DINO induction and p53 activation. Mechanistically, NR2E3 loss both

Identifiants

pubmed: 30991008
doi: 10.1096/fj.201801881RR
pmc: PMC6593879
doi:

Substances chimiques

Nr2e3 protein, mouse 0
Orphan Nuclear Receptors 0
RNA, Long Noncoding 0
Trp53 protein, mouse 0
Tumor Suppressor Protein p53 0
Acetaminophen 362O9ITL9D
Acetylcysteine WYQ7N0BPYC

Types de publication

Journal Article Research Support, N.I.H., Extramural

Langues

eng

Sous-ensembles de citation

IM

Pagination

8335-8348

Subventions

Organisme : NIEHS NIH HHS
ID : P30 ES006096
Pays : United States

Références

Nat Genet. 2000 Feb;24(2):127-31
pubmed: 10655056
Toxicol Sci. 2001 Jan;59(1):169-77
pubmed: 11134556
Nature. 2001 Mar 1;410(6824):120-4
pubmed: 11242054
Proc Natl Acad Sci U S A. 2001 Apr 10;98(8):4611-6
pubmed: 11287661
Proc Natl Acad Sci U S A. 2002 Jan 8;99(1):473-8
pubmed: 11773633
Nat Genet. 2002 Mar;30(3):329-34
pubmed: 11850619
Nature. 2002 Sep 26;419(6905):407-11
pubmed: 12353038
Nat Genet. 2003 Mar;33(3):396-400
pubmed: 12567186
Cell Mol Life Sci. 2003 Jan;60(1):6-20
pubmed: 12613655
Nucleic Acids Res. 2003 Jul 1;31(13):3651-3
pubmed: 12824386
Cell. 2004 Dec 29;119(7):941-53
pubmed: 15620353
Toxicol Sci. 2006 Jan;89(1):31-41
pubmed: 16177235
Hepatology. 2005 Dec;42(6):1364-72
pubmed: 16317692
Gastroenterology. 2006 Jul;131(1):165-78
pubmed: 16831600
J Biochem Mol Biol. 2006 Sep 30;39(5):479-91
pubmed: 17002867
J Biol Chem. 2007 Mar 2;282(9):5969-72
pubmed: 17218320
Nature. 2007 Aug 9;448(7154):718-22
pubmed: 17687328
Hepatology. 2008 Apr;47(4):1401-15
pubmed: 18318440
J Biol Chem. 2008 May 16;283(20):13565-77
pubmed: 18337250
Toxicol Appl Pharmacol. 2010 Jul;246(1-2):8-17
pubmed: 20423716
Cell. 2010 Jul 9;142(1):89-100
pubmed: 20598361
Mol Cell. 2010 Dec 22;40(6):939-53
pubmed: 21172659
Cell Death Differ. 2011 Jul;18(7):1130-9
pubmed: 21233848
Hepatology. 2011 Sep 2;54(3):969-78
pubmed: 21626531
Mol Cell Biol. 2012 Jan;32(1):26-35
pubmed: 22025681
EMBO Mol Med. 2012 Jan;4(1):52-67
pubmed: 22174013
Trends Genet. 2012 Mar;28(3):128-36
pubmed: 22265392
Curr Mol Med. 2012 Sep;12(8):901-16
pubmed: 22671997
Science. 2012 Jun 15;336(6087):1440-4
pubmed: 22700930
World J Gastroenterol. 2013 Jun 28;19(24):3781-91
pubmed: 23840116
Nat Protoc. 2014 Aug;9(8):1956-68
pubmed: 25058643
Neoplasia. 2014 Dec;16(12):1059-69
pubmed: 25499219
Nat Methods. 2015 Jun;12(6):479
pubmed: 26020497
Toxicol Lett. 2015 Sep 17;237(3):228-36
pubmed: 26149760
Arch Toxicol. 2017 Feb;91(2):761-773
pubmed: 27002509
Genome Biol. 2016 Jul 05;17(1):148
pubmed: 27380939
Nat Genet. 2016 Nov;48(11):1370-1376
pubmed: 27668660
Free Radic Biol Med. 2017 May;106:111-117
pubmed: 28196650
Sci Rep. 2017 Sep 6;7(1):10662
pubmed: 28878246
Toxicol Rep. 2015 Aug 10;2:1149-1156
pubmed: 28962456
Adv Exp Med Biol. 2017;1016:75-90
pubmed: 29130154
N Engl J Med. 1988 Dec 15;319(24):1557-62
pubmed: 3059186
EMBO J. 1988 May;7(5):1395-402
pubmed: 3409869
J Pharmacol Exp Ther. 1986 Jul;238(1):54-61
pubmed: 3723405
Biochem Pharmacol. 1984 Oct 1;33(19):2995-3000
pubmed: 6487352
Lancet. 1977 Aug 27;2(8035):432-4
pubmed: 70646
Cell. 1993 Jan 15;72(1):73-84
pubmed: 8422685
J Biol Chem. 1996 May 17;271(20):12063-7
pubmed: 8662637

Auteurs

Tilak Khanal (T)

Department of Environmental Health, College of Medicine, University of Cincinnati, Cincinnati, Ohio, USA.

Yuet-Kin Leung (YK)

Department of Environmental Health, College of Medicine, University of Cincinnati, Cincinnati, Ohio, USA.

Wang Jiang (W)

Department of Pathology and Laboratory Medicine, College of Medicine, University of Cincinnati, Cincinnati, Ohio, USA.

Nicolai Timchenko (N)

Division of Pediatric General and Thoracic Surgery, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, USA.

Shuk-Mei Ho (SM)

Department of Environmental Health, College of Medicine, University of Cincinnati, Cincinnati, Ohio, USA.

Kyounghyun Kim (K)

Department of Environmental Health, College of Medicine, University of Cincinnati, Cincinnati, Ohio, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH